Medtronic plc (FRA:2M6)
76.34
-0.90 (-1.17%)
Last updated: May 13, 2025
Revenue by Product
Fiscal year is May - April.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
Cardiac Rhythm & Heart Failure |
Log In |
Log In |
Log In |
Log In |
Cardiac Rhythm & Heart Failure Growth |
Log In |
Log In |
Log In |
Log In |
Cardiovascular |
Log In |
Log In |
Log In |
Log In |
Cardiovascular Growth |
Log In |
Log In |
Log In |
Log In |
Neuroscience |
Log In |
Log In |
Log In |
Log In |
Neuroscience Growth |
Log In |
Log In |
Log In |
Log In |
Diabetes |
Log In |
Log In |
Log In |
Log In |
Diabetes Growth |
Log In |
Log In |
Log In |
Log In |
Medical Surgical |
Log In |
Log In |
Log In |
Log In |
Medical Surgical Growth |
Log In |
Log In |
Log In |
Log In |
Structural Heart & Aortic |
Log In |
Log In |
Log In |
Log In |
Structural Heart & Aortic Growth |
Log In |
Log In |
Log In |
Log In |
Coronary & Peripheral Vascular |
Log In |
Log In |
Log In |
Log In |
Coronary & Peripheral Vascular Growth |
Log In |
Log In |
Log In |
Log In |
Cranial & Spinal Technologies |
Log In |
Log In |
Log In |
Log In |
Cranial & Spinal Technologies Growth |
Log In |
Log In |
Log In |
Log In |
Specialty Therapies |
Log In |
Log In |
Log In |
Log In |
Specialty Therapies Growth |
Log In |
Log In |
Log In |
Log In |
Neuromodulation |
Log In |
Log In |
Log In |
Log In |
Neuromodulation Growth |
Log In |
Log In |
Log In |
Log In |
Surgical & Endoscopy |
Log In |
Log In |
Log In |
Log In |
Surgical & Endoscopy Growth |
Log In |
Log In |
Log In |
Log In |
Acute Care & Monitoring |
Log In |
Log In |
Log In |
Log In |
Acute Care & Monitoring Growth |
Log In |
Log In |
Log In |
Log In |
Other Segment |
Log In |
Log In |
Log In |
Log In |
Other Segment Growth |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is May - April.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
Cardiovascular Operating Profit |
Log In |
Log In |
Log In |
Log In |
Cardiovascular Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Neuroscience Operating Profit |
Log In |
Log In |
Log In |
Log In |
Neuroscience Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Medical Surgical Operating Profit |
Log In |
Log In |
Log In |
Log In |
Medical Surgical Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Diabetes Operating Profit |
Log In |
Log In |
Log In |
Log In |
Diabetes Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is May - April.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
U.S. |
Log In |
Log In |
Log In |
Log In |
U.S. Growth |
Log In |
Log In |
Log In |
Log In |
Non-U.S. Developed Markets |
Log In |
Log In |
Log In |
Log In |
Non-U.S. Developed Markets Growth |
Log In |
Log In |
Log In |
Log In |
Emerging Markets |
Log In |
Log In |
Log In |
Log In |
Emerging Markets Growth |
Log In |
Log In |
Log In |
Log In |
Total International |
Log In |
Log In |
Log In |
Log In |
Total International Growth |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is May - April.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
Total Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |
Cardiovascular Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |
Neuroscience Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |
Medical Surgical Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |
Diabetes Organic Revenue Growth |
Log In |
Log In |
Log In |
Log In |